Using intrathecal L-selectin function-blocking antibodies or inhibitors may provide valuable mechanistic evidence linking spinal L-selectin expression and neutrophil invasion with the pathogenesis of diabetic neuropathy. The gene discussed is SELL; the disease is diabetic neuropathy.